1 |
Akbulut, H., Zhang, L., Tang, Y, and Deisseroth, A., Cytotoxic effect of replication-competent adenoviral vectors carrying Lplastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon. Cancer Gene Ther., 10(5), 388-395(2003)
DOI
ScienceOn
|
2 |
Kufe, D. W. and Major, P. P., 5-Fluorouracil incorporation into human breast carcinoma RNA correlates with cytotoxicity. J. Biol. Chem., 256, 9802-9805(1991)
|
3 |
Leavitt, J., Discoveryand characterization of two novel huamn cancer-related proteins using two-dimensional gel electrophoresis. Electrophoresis, 15, 345-357(1994)
DOI
ScienceOn
|
4 |
Lin, C.-S., Park, T., Chen, Z. P., and Leavitt, J. L., Human plastin genes.J. Biol. Chem., 268(4), 2781-2792 (1993b)
PUBMED
|
5 |
Anderson, L., Kilstrup, M., and Neuhard, J., Pyrimidine, purine and nitrogen conrol of cytosine deaminase synthesis in Escherichia coli K12. Involvement of the glnG and purR genes in the resgulation of codA expression. Arch. Microbiol., 152, 115-118 (1989)
DOI
ScienceOn
|
6 |
Miller, N. and Whelan, J., Progress in transcriptionally targeted and regulatable vectors for genetic therapy. Human Gene Ther., 8, 803-815 (1997)
DOI
ScienceOn
|
7 |
Zhang, W. W., Fang, X., Branch, C. D., Mazur, W., French, B. A., and Roth, J. A., Generation and identification of recombinant adenovirus by liposome-mediated transfection and PCR analysis. Biotechnques, 15(5), 868-872 (1993)
|
8 |
Lin, C.-S., Chen, Z. P., Park, T., Ghosh, K., and Leavitt, J., Characterization of the human L-plastin gene promoter in normal and neoplastic cells. J. Biol. Chem., 268(4), 2793-2801 (1993a)
PUBMED
|
9 |
Graham, F. L., and Prevec, L., Manipulation of adenovirus vectors, Methods in molecularbiology, Vol. 7, p109-128, E. J. Murray, The Human Press Inc., Clifton, NJ. (1991)
|
10 |
Chung, I., Schwartz, P. E., Crystal, R. G., Pizzorno, G., Leavitt, J., and Deisseroth, A. B., Use of L-plastin promoter to develop an adenoviral system that confers transgene expression in ovarian cancercells but not in normal mesothelial cells. Cancer Gene Ther, 6 (2), 99-106 (1999)
DOI
ScienceOn
|
11 |
Glazer, R. I. and Lloyd, L. S., Association of cell lethality with incorporation of 5-fluorouracil and 5-fluoridine into nuclear RNA in human colon carcinoma cells in culture. Mol. Pharmacol., 21, 468-473 (1992)
|
12 |
Moolten, F. L., Drug sensitivity ('suicide') genes for selective cancer chemotherapy. Cancer Gene Ther., 1, 279-287 (1994)
PUBMED
|
13 |
Austin, E. A., and Huber, B. E., A first step in the development of gene therapy for colorectal carcinoma: cloning, sequencing, and expression of E. coli cytosine deaminse. Mol. Pharmacol., 43, 380-387(1993)
PUBMED
|
14 |
Cannistra, S. A., Cancerof the ovary. N. Engl. J. Med., 329(21), 1550-1559(1995)
DOI
ScienceOn
|
15 |
Huber, B. E., Austin, E. A., Good, S. S., Knick, V. C., Tibbels, S., and Richards, C. A., In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically codified to express cytosine deaminase. Cancer Res., 53, 4619-4626 (1993)
PUBMED
|
16 |
Hirschowitz, E. A., Ohwada, A., Pascal, W. R., Russi, T. J., and Crysta, R. G., In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Human Gene Ther., 6(8), 1055-1063 (1995)
DOI
ScienceOn
|
17 |
Peng, X. Y., Won, J. H., Rutherford, T., Fujii, T., Zelterman, D., Pizzorno, G., Sapi, E., Leavitt, J., Kacinski, B., Crystal, R., Schwartz, P., and Deisseroth, A., The use of the L-plastin promoter for adenoviral-mediated , tumor-specific gene expression in ovarian and bladder cancer cell lines. Cancer Res., 61(11),4405-4413 (2001)
PUBMED
|
18 |
Pritchard, D. M., Watson, A. J., Potten, C. S., Jackman, A. L., and Hickman, J. A., Inhibition by uridine but not thymidine fo p53-dependent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. Proc. Natl. Acad. Sci. U.S.A., 94(5), 1795-1799 (1997)
DOI
ScienceOn
|